Delivery Order SPE2DR25D1200-SPE2DR26FMK8M

The Defense Logistics Agency awarded a $36,642.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in patients with established coronary artery disease. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026.

AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capacity to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide while also serving customers including the Defense Health Agency and the U.S. Coast Guard. The company competes on a full and open basis for federal contracts and is registered in the System for Award Management.